MST1 and metabolic dysfunction-associated steatohepatitis: Previous studies have indicated that MSP inhibits the expression of pro-inflammatory cytokines in HepG2 cells and acts as a negative regulator of inflammation in a non-alcoholic steatohepatitis model [27].